NEW YORK (Reuters Health) - People who smoke or who have high blood pressure or diabetes in middle age are more likely to ...
ASK YOUR DOCTOR IF THIS AD IS RIGHT FOR YOU Does it seem like you hear the phrase "ask your doctor" every time ...
WASHINGTON - OCTOBER 28: National Football League Commissioner Roger Goodell (R) greets Pro Football Hall of Fame player Willie Woods (green cap) before a hearing of the House Judiciary Committee about football brain injuries on Captiol Hill October 28, 2009 in Washington, ...
2009 Rita Hayworth Alzheimer's Gala Waldorf Astoria Hotel, New York City 10-27-2009 Photo By Judie Burstein-Globe Photos, Inc. 2009 Copyright 2009 Globe Photos
Amgen shares fall as company discloses additional FDA Prolia request, Arenesp data Amgen Inc. shares fell Thursday over the likelihood that the biotechnology company's next potential blockbuster will take longer than expected to reach its full sales potential in the market. Shares ...
Amgen's 3rd-quarter profit up 24 percent on lower costs, osteoporosis drug could face delays Biotechnology company Amgen Inc. said Wednesday lower costs in its research and sales units boosted third-quarter profit by 24 percent, despite a continued downturn in anemia drug sales. ...
Amgen Inc. said Monday the Food and Drug Administration wants more information about its osteoporosis treatment Prolia before granting marketing approval. It delays a drug seen as a potential blockbuster for the company. In a letter, the FDA said it wants to ...
Many elderly with dementia and kidney failure in nursing homes get futile care, studies show A surprising number of frail, elderly Americans in nursing homes are suffering from futile care at the end of their lives, two new federally funded studies reveal. ...
NEW YORK (Reuters Health) - Advanced dementia is a terminal illness and should be viewed as such, researchers conclude in a report released Wednesday. Infections and eating problems are common and often herald the final states of life for these patients. Unfortunately, ...
UBS analyst boosts price target for Amgen stock, citing osteoporosis drug, stable business A UBS analyst on Monday boosted his price target on Amgen Inc., saying the launch of the company's osteoporosis drug denosumab should drive the stock's value. UBS analyst Maged ...
NEW YORK (Reuters Health) - Sorry coffee lovers -- downing a few cups of coffee throughout the day may spark alertness, but it's unlikely to protect the aging brain from mental decline or dementia, according to researchers from Finland. Some studies have ...
LONDON (Reuters) - Millions of people suffering with dementia are often left without care or support until their illness reaches crisis point, according to a report on Thursday on the ethical dilemmas of the brain-wasting disease. The report by a British medical ...
